肺癌放疗后胸部影像学表现
本文综述肺癌患者接受常规分割外照射或高精度放疗(包括三维适形放疗、立体定向体部放疗、调强放疗和质子治疗)后胸部影像学表现,讨论影响放射性肺损伤发生与严重程度的因素,重点比较常规放疗与高精度放疗技术的影像学差异。
要点
- 了解所用放疗技术、放疗计划及放射性肺损伤的预期时间演变对影像解读很重要。
- 患者既往放疗史、同步放化疗和/或免疫治疗等个体因素影响放射性肺损伤的发生与严重程度。
- 常规放疗与高精度放疗技术的放射性肺损伤影像学表现存在差异。
核心结论
- 肺癌放疗后影像解读需结合放疗技术、放疗计划、放射性肺损伤的预期时间演变及患者个体因素(既往放疗、同步放化疗和/或免疫治疗),并注意常规放疗与高精度放疗技术的影像学差异。
研究设计与样本
- 综述,讨论影响放射性肺损伤发生与严重程度的因素及其影像学表现,重点比较常规放疗与高精度放疗技术的差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Radiation therapy using conventional fractionated external-beam or high-precision dose techniques including three-dimensional conformal radiotherapy, stereotactic body radiation therapy, intensity-modulated radiation therapy, and proton therapy, is a key component in the treatment of patients with lung cancer. Knowledge of the radiation technique used, radiation treatment plan, expected temporal evolution of radiation-induced lung injury and patient-specific parameters, such as previous radiotherapy, concurrent chemoradiotherapy, and/or immunotherapy, is important in imaging interpretation. This review discusses factors that affect the development and severity of radiation-induced lung injury and its radiological manifestations with emphasis on the differences between conventional radiation and high-precision dose radiotherapy techniques.
引用
- Strange CD, Shroff GS, Truong MT, et al. Imaging of the post-radiation chest in lung cancer. Clin Radiol. 2021. PMID: 34090709. doi:10.1016/j.crad.2021.04.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。